Literature DB >> 23247511

IBD: Can TNF inhibitors be administered during the third trimester?

Ole Haagen Nielsen1, Tine Jess.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23247511     DOI： 10.1038/nrgastro.2012.248

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  9 in total

Review 1.  A meta-analysis on the influence of inflammatory bowel disease on pregnancy.

Authors:  J Cornish; E Tan; J Teare; T G Teoh; R Rai; S K Clark; P P Tekkis
Journal:  Gut       Date:  2006-12-21       Impact factor: 23.059

2.  Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes.

Authors:  Deepa Reddy; Seamus J Murphy; Sunanda V Kane; Daniel H Present; Asher A Kornbluth
Journal:  Am J Gastroenterol       Date:  2008-04-16       Impact factor: 10.864

3.  Unintended pregnancy: worldwide levels, trends, and outcomes.

Authors:  Susheela Singh; Gilda Sedgh; Rubina Hussain
Journal:  Stud Fam Plann       Date:  2010-12

4.  Detection of infliximab in breast milk of nursing mothers with inflammatory bowel disease.

Authors:  Shomron Ben-Horin; Miri Yavzori; Uri Kopylov; Orit Picard; Ella Fudim; Rami Eliakim; Yehuda Chowers; Alon Lang
Journal:  J Crohns Colitis       Date:  2011-12       Impact factor: 9.071

5.  High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy.

Authors:  Z Zelinkova; C de Haar; L de Ridder; M J Pierik; E J Kuipers; M P Peppelenbosch; C J van der Woude
Journal:  Aliment Pharmacol Ther       Date:  2011-03-01       Impact factor: 8.171

Review 6.  The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics.

Authors:  Uma Mahadevan; Salvatore Cucchiara; Jeffrey S Hyams; Flavio Steinwurz; F Nuti; Simon P L Travis; William J Sandborn; Jean-Frederio Colombel
Journal:  Am J Gastroenterol       Date:  2010-12-14       Impact factor: 10.864

7.  Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study.

Authors:  Jason A Dominitz; Josephine C C Young; Edward J Boyko
Journal:  Am J Gastroenterol       Date:  2002-03       Impact factor: 10.864

Review 8.  Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient.

Authors:  F M Habal; V W Huang
Journal:  Aliment Pharmacol Ther       Date:  2012-01-05       Impact factor: 8.171

9.  Effects of discontinuing anti-tumor necrosis factor therapy during pregnancy on the course of inflammatory bowel disease and neonatal exposure.

Authors:  Zuzana Zelinkova; Cokkie van der Ent; Karlien F Bruin; Onno van Baalen; Hestia G Vermeulen; Herman J T Smalbraak; Rob J Ouwendijk; Aad C Hoek; Sjoerd D van der Werf; Ernst J Kuipers; C Janneke van der Woude
Journal:  Clin Gastroenterol Hepatol       Date:  2012-10-25       Impact factor: 11.382
  9 in total
  1 in total

Review 1.  Safety of TNF-α inhibitors during IBD pregnancy: a systematic review.

Authors:  Ole Haagen Nielsen; Edward V Loftus; Tine Jess
Journal:  BMC Med       Date:  2013-07-31       Impact factor: 8.775
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.